Ciglitazone
-
Ciglitazone
structure -
-
CAS No:
74772-77-3
-
Formula:
C18H23NO3S
-
Chemical Name:
Ciglitazone
-
Synonyms:
2,4-Thiazolidinedione,5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]-;5-[[4-[(1-Methylcyclohexyl)methoxy]phenyl]methyl]-2,4-thiazolidinedione;ADD 3878;Ciglitazone;U 63287
- Categories:
-
CAS No:
Description
White Cyrstalline Solid
Ciglitazone is an aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist. It has a role as an insulin-sensitizing drug and an antineoplastic agent. It is a thiazolidinone and an aromatic ether.|Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market. Ciglitazone significantly decreases VEGF production by human granulosa cells in an in vitro study, and may potentially be used in ovarian hyperstimulation syndrome. Ciglitazone is a potent and selective PPARγ ligand with an EC50 of 3.0 µM. It is also an anti-hyperglycemic agent in the ob/ob murine model in vivo. Ciglitazone increases adipogenesis, decreases differentiation and angiogenesis in human umbilical vein endothelial cell (HUVEC), and osteoblastogenesis in human mesenchymal stem cells.
Characteristics
80.7
4.69
white cyrstalline solid
1.2±0.1 g/cm3
130-131 °C @ Solvent: Ethanol
504.5±23.0 °C at 760 mmHg
258.9±22.6 °C
1.568
Store at RT
Safety Information
NONH for all modes of transport
3
XJ5813700
P201, P202, P281, P308+P313, P405, P501
H361
|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
5-(4-(1-methylcyclohexylmethoxy)benzyl)thiazolidine-2,4-dione
Ciglitazone Use and Manufacturing
Displays antihyperglycemic activity in genetically obese mice. It is a selective PPARg agonist
Computed Properties
Molecular Weight:333.4
XLogP3:4.8
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:333.13986477
Monoisotopic Mass:333.13986477
Topological Polar Surface Area:80.7
Heavy Atom Count:23
Complexity:440
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Oils, Chenopodium
8006-99-3
-
2-Methyl-4-phenyl-2-butanol
103-05-9
-
Fats and Glyceridic oils, pumpkin seed
8016-49-7
-
Polysiloxanes, Me Ph Formula
63148-58-3
-
Frankincense resin Formula
8050-07-5
-
(1R,2R,4aS,8aS)-1-[(3E)-6-[(1S)-2,2-Dimethyl-6-methylenecyclohexyl]-4-methyl-3-hexenyl]decahydro-2,5,5,8a-tetramethyl-2-naphthalenol Formula
473-03-0
-
Michelia alba, ext. Structure
92457-18-6
-
Resins, Siam gum benzoin Structure
9000-72-0
-
What is Terpenes and Terpenoids, sweet orange-oil
68647-72-3
-
What is Oils, Cyperusscariosus
68916-60-9